Newsletters
EARLWelcome to the dosage calculator
In order to broaden the range of functions of our online services and to make the use of our site more comfortable for you, we use what are referred to as cookies. With the help of these cookies, data can be stored on your computer upon visiting our website. It is possible for you to prevent cookies from being saved on your computer by adjusting the relevant settings in your web browser. This can, however, limit the range of functions offered by our website.
Calculation of the administered activity in [MBq] and [mCi]
1
2
3
Select radiopharmaceutical
Select weight
Chosen options:
Radiopharmaceutical:
previous step
Activity to be administered:
= MBq or mCi
Chosen options:Radiopharmaceutical:
Weight:
Important notes
The minimum and maximum values correspond to the recommended administered activities in the EANM/ESC procedural guidelines (Hesse B, Tagil K, Cuocolo A, et al.). EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):855-97.
This card is based upon the publication by Jacobs F, Thierens H, Piepsz A, Bacher K, Van de Wiele C, Ham H, Dierckx RA. Optimized tracer-dependent dosage cards to obtain weight independent effective doses. Eur J Nucl Med Mol Imaging. 2005 May; 32(5):581-8.
M. Lassmann, S.T.Treves. Pediatric Radiopharmaceutical Administration: Harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the 2010 North America Consensus guideline, Eur J Nucl Med Mol Imaging. 2014, DOI: 10.1007/s00259-014-2731-9.
Lassmann M, Biassoni L, Monsieurs M, Franzius C; EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging. 2008 Sep;35(9):1666-8. DOI: 10.1007/s00259-008-0799-9. Epub 2008 Jun 24. Erratum in: Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2141
This card summarises the views of the Paediatric and Dosimetry Committees of the EANM and reflects recommendations for which the EANM cannot be held responsible. The dosage recommendations should be taken in the context of “good practice” of nuclear medicine and do not substitute for national and international legal or regulatory provisions.